Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Haleh Bagheri »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hakan Widner < Haleh Bagheri < Hamid Azzedine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000177 (2011) Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
000185 (2011) Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
000391 (2005) Agnès Sommet [France] ; Cécile Azaïs-Vuillemin [France] ; Haleh Bagheri [France] ; Olivier Rascol [France] ; Jean Louis Montastruc [France]Trimetazidine: A new cause for drug‐induced parkinsonism?
000429 (2004) Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France]New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance
000435 (2004) Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France]Dopaminagonists and fibrotic valvular heart disease: Further considerations

List of associated KwdEn.i

Nombre de
documents		Descripteur
4Humans
2Dopamine Agonists (adverse effects)
2Female
2France
2Heart Valve Diseases (chemically induced)
2Pergolide (adverse effects)
2Pharmacovigilance
1Age Factors
1Aged
1Aged, 80 and over
1Antipsychotic
1Antipsychotic Agents (adverse effects)
1Calcium antagonist
1Disclosure
1Ergot Alkaloids (analysis)
1Experience
1Fibrosis (chemically induced)
1Health Education
1Hypertension (drug therapy)
1International Cooperation
1Longitudinal Studies
1Male
1Mental Status Schedule
1Nervous system diseases
1Neuroleptic
1Parkinson Disease (drug therapy)
1Parkinson Disease, Secondary (chemically induced)
1Parkinsonian Disorders (chemically induced)
1Parkinsonism
1Pergolide (chemistry)
1Retrospective Studies
1Risk Factors
1Safety
1Time Factors
1Trimetazidine (adverse effects)
1Vasodilator Agents (adverse effects)
1adverse drug reactions
1antipsychotics
1calcium channel blockers
1dopaminergic antagonists
1drug safety
1neuroleptics
1parkinsonism
1pharmacovigilance

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Haleh Bagheri" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Haleh Bagheri" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Haleh Bagheri
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024